Article

Discovery of selective GluN1/GluN3A NMDA receptor inhibitors using integrated AI and physics-based approaches

Shi-wei Li1, Yue Zeng2,3,4, Sa-nan Wu1, Xin-yue Ma5, Chao Xu1, Zong-quan Li5, Sui Fang2, Xue-qin Chen2, Zhao-bing Gao2,3,6, Fang Bai1,5,7
1 Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China
2 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
3 University of Chinese Academy of Sciences, Beijing 100049, China
4 Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 200032, China
5 School of Information Science and Technology, ShanghaiTech University, Shanghai 201210, China
6 Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China
7 Shanghai Clinical Research and Trial Center, Shanghai 201210, China
Correspondence to: Zhao-bing Gao: zbgao@simm.ac.cn, Fang Bai: baifang@shanghaitech.edu.cn,
DOI: 10.1038/s41401-025-01607-6
Received: 13 January 2025
Accepted: 3 June 2025
Advance online: 14 July 2025

Abstract

N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels essential for synaptic transmission and plasticity in the central nervous system. GluN1/GluN3A, an unconventional NMDAR subtype functioning as an excitatory glycine receptor, has been implicated in mood regulation, with high expression in brain regions governing emotional and motivational states. However, therapeutic exploration has been significantly hindered by a lack of potent and selective modulators, limited structural data and the intrinsic complexity of ion channels. Here, we introduce a compound virtual screening pipeline that combines artificial intelligence and physical models, integrating two sequence-based deep learning prediction models (TEFDTA and ESMLigSite) with a molecular docking approach. This approach was employed to identify potential inhibitors against GluN1/GluN3A by screening a commercial database containing 18 million compounds. The strategy resulted in an impressive hit rate of 50% for discovering inhibitors, with the most promising compound exhibiting strong inhibitory activity (IC50 = 1.26 ± 0.23 μM) and remarkable target specificity (>23-fold selectivity over the GluN1/GluN2A receptor). These findings highlight the effectiveness of AI-assisted strategies in addressing challenges related to unconventional ion channels and pave the way for new therapeutic exploration.

Keywords: N-methyl-D-aspartate receptors; GluN1/GluN3A; deep learning; molecular docking; virtual screening; binding site identification

Article Options

Download Citation

Cited times in Scopus